Coil Assisted Flow Diverters Market to Grow at a CAGR of 7.6% to reach US$ 465.85 million from 2021 to 2028

Free Sample PDF Inquiry Before Buying
Medical Device Coil Assisted Flow Diverters Market
report image

Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Wide-Neck Bifurcation Aneurysms and Narrow-Neck Bifurcation Aneurysms) and End User (Hospitals, Clinics, and Ambulatory Surgical Centers)

Publication Month: Jun 2021 | Report Code: TIPRE00022687 | No. of Pages: 145 | Category: Medical Device | Status: Published

The coil assisted flow diverters market is expected to reach US$ 465.85 million by 2028 from US$ 278.23 million in 2021; it is estimated to grow at a CAGR of 7.6% during 2021–2028.

Coil assisted flow diverter is an adjunctive intrasaccular stent made of super visible braid elastic matter and is less restrictive. It is designed for the placement of embolization coils in the treatment of aneurysms. Coil assisted flow diverter also possesses mesh braid of contour neurovascular system, with memory properties, self-anchoring, stabilizing and less restricting sizing with the help of high precision re-sheathable placement into the aneurysm sac neck. The growth of the coil assisted flow diverters market is attributed to the factors such as rising incidence of intracranial aneurysms and growing incidence of hypertension, obesity, smoking, and alcoholism. However, the high cost of neurosurgical devices hinders the market growth.  

Lucrative Regions for Coil Assisted Flow Diverters Market


Lucrative Regions for Coil Assisted Flow Diverters Market

Get more information on this report :


Market Insights

Rising Incidence of Intracranial Aneurysms

Coil assisted flow diverters are stent-like devices used for the embolization of intracranial aneurysms. The incidence of intracranial aneurysms is increasing across the world. For instance, the Brain Aneurysm Foundation, Statistics and Facts report stated that around 6.5 million people (that is 1 in 50 people) in the US have an unruptured brain aneurysm. The report has also mentioned that 20% of the total people diagnosed with a brain aneurysm have more than one aneurysm. It has further reported that, every year, around 30,000 people in the US suffer from a brain aneurysm rupture, and a brain aneurysm rupture takes place in every 18 minutes. Also, Brain Aneurysm Foundation of Canada reported that about 8 to 10 people in 100,000, or around 2,800 to 3,500 Canadians, suffer from a burst aneurysm every year, which accounts for about 3% of all hemorrhagic strokes. Further, as per the National Health Service (NHS), 1 in 12,500 people have a ruptured brain aneurysm in England each year. Additionally, as per the ‘Unruptured Intracranial Aneurysms—Pathogenesis and Individualized Management’ report published in Deutsches Ärzteblatt International in 2020, around 2 million adults in Germany have an unruptured intracranial aneurysm (IA). Thus, the increasing prevalence of intracranial aneurysms drives the growth of the coil assisted flow diverters market.

Application-Based Insights

The coil assisted flow diverters market, by application, is bifurcated into wide-neck bifurcation aneurysms and narrow neck bifurcation aneurysms. The wide-neck bifurcation aneurysms segment held a larger market share in 2021, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.

Coil Assisted Flow Diverters Market, by Application – 2021 and 2028


Coil Assisted Flow Diverters Market, by Application – 2021 and 2028

Get more information on this report :


End User -Based Insights

The coil assisted flow diverters market, by end user, is segmented into hospitals, clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Report Coverage - Coil Assisted Flow Diverters Market
Report CoverageDetails
Market Size Value inUS$ 278.23 Million in 2021
Market Size Value byUS$ 465.85 Million by 2028
Growth rateCAGR of 7.6% from 2021-2028
Forecast Period2021-2028
Base Year2021
No. of Pages145
No. of Tables57
No. of Charts & Figures66
Historical data availableYes
Segments coveredApplication and End User
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, players operating in the coil assisted flow diverters market focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

Coil Assisted Flow Diverters Market – by Application

  • Wide-Neck Bifurcation Aneurysms
  • Narrow-Neck Bifurcation Aneurysms

Coil Assisted Flow Diverters Market – by End User  

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Coil Assisted Flow Diverters Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Balt USA LLC
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • Penumbra, Inc.
  • Medtronic.
  • Acandis GmbH
  • MicroVention Inc
  • Johnson and Johnson Services, Inc.
  • Lepu Medical Technology Co. Ltd.
  • Cerus Endovascular

Frequently Asked Questions

What are Coil Assisted Flow Diverters?
Coil assisted flow diverters is an adjunctive intrasaccular stent which is made of super visible braid elastic matter and is less restrictive .It is designed for application with embolization coils for the treatment of aneurysms. It also possesses mesh braid of contour neurovascular system, with memory properties, self-anchoring, stabilizing and less restricting sizing with the help of high precision re-sheathable placement into the aneurysm sac neck.
What are the driving factors for the coil assisted flow diverters market across the globe?
The growth of the market is attributed to some key driving factors such as the rising incidence of intracranial aneursyms, growing incidence of hypertension, smoking, alcoholism, and obesity. For instance, In December 2020, Terumo Corporation launched WEB Embolization System (Product name in Japan: Woven EndoBridge Device), an intrasaccular aneurysm treatment device, in Japan. The WEB device is an innovative intrasaccular flow disruptor device and provides new treatment options for brain aneurysm cases. Such strategic steps are also projected to drive the market growth.
What is the regional analysis in terms of coil assisted flow diverters market?
The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the North America is expected account for the fastest growth in the coil assisted flow diverters market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical device growth of coil assisted flow diverters market during the forecast period.

The List of Companies - Coil Assisted Flow Diverters Market

  1. Balt USA LLC
  2. MicroPort Scientific Corporation
  3. Stryker Corporation
  4. Penumbra, Inc.
  5. Medtronic.
  6. Acandis GmbH
  7. MicroVention Inc
  8. Johnson and Johnson Services, Inc.
  9. Lepu Medical Technology Co. Ltd.
  10. Cerus Endovascular
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the coil assisted flow diverters market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global coil assisted flow diverters market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00022687
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Download PDF Brochure

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
Sample Download Download Free Sample

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount